VYNE THERAPEUTICS INC. (YARW) Free cash flow 2016–2025
VYNE THERAPEUTICS INC. (YARW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$33.1MFY2025 · since FY2016: -$2.3M → -$33.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.1M | +2.8% |
| FY2024 | -$34.1M | -34.5% |
| FY2023 | -$25.3M | — |
| FY2021 | -$56.4M | +58.9% |
| FY2020 | -$137.2M | -84.3% |
| FY2019 | -$74.5M | -7.5% |
| FY2018 | -$69.2M | -145.1% |
| FY2017 | -$28.2M | -1130.4% |
| FY2016 | -$2.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice